A detailed history of Jpmorgan Chase & CO transactions in Hyperfine, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,581 shares of HYPR stock, worth $2,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,581
Previous 2,713 4.87%
Holding current value
$2,581
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$0.9 - $1.24 $118 - $163
-132 Reduced 4.87%
2,581 $2,000
Q2 2024

Aug 12, 2024

BUY
$0.79 - $1.02 $6 - $8
8 Added 0.3%
2,713 $2,000
Q1 2024

May 10, 2024

BUY
$0.96 - $1.25 $35 - $46
37 Added 1.39%
2,705 $2,000
Q4 2023

Feb 12, 2024

BUY
$1.03 - $1.99 $26 - $51
26 Added 0.98%
2,668 $2,000
Q3 2023

Nov 14, 2023

BUY
$1.85 - $3.17 $112 - $193
61 Added 2.36%
2,642 $5,000
Q4 2022

Feb 13, 2023

BUY
$0.71 - $1.29 $1,832 - $3,329
2,581 New
2,581 $2,000
Q1 2022

May 11, 2022

BUY
$2.63 - $7.38 $6,788 - $19,047
2,581 New
2,581 $9,000

Others Institutions Holding HYPR

About Hyperfine, Inc.


  • Ticker HYPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,515,500
  • Market Cap $55.5M
  • Description
  • Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.
More about HYPR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.